A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial of a Neurokinin-1 Receptor Antagonist for Overactive Bladder
Keywords: receptors; neurokinin-1; tolterodine; muscarinic antagonists; urinary bladder; overactiveAE, adverse experience; ER, extended release; LS, least squares; NK-1R, neurokinin-1 receptor; OAB, overactive bladder; SP, substance P; TKs, tachykinins